This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The $51.9M contract, with a period of performance through February 2026, is for the delivery of pediatric influenza vaccines to support the CDC's immunization programs.
As a Multiple Award IDC, this contract provides a streamlined acquisition vehicle for the CDC to procure influenza vaccines and other pharmaceutical products and medical countermeasures from AstraZeneca on an as-needed basis through the issuance of task orders. AstraZeneca has extensive experience supplying vaccines, therapeutics, and other medical products to federal agencies including the Department of Health and Human Services, Department of Defense, and Department of Veterans Affairs through prime contracts, grants, and IDVs. The scope and pricing for task orders released under this IDC will be based on the original solicitation requirements and AstraZeneca's negotiated price list.
Generated 1/23/25, 9:04 AM